Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Konstantin Seitzer"'
Autor:
Neele Wüstmann, Konstantin Seitzer, Verena Humberg, Julia Vieler, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Stefan Duensing, Laura-Maria Krabbe, Martin Bögemann, Andres Jan Schrader, Christof Bernemann, Katrin Schlack
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-14 (2023)
Abstract Background Androgen receptor (AR) splice variants (AR-Vs) have been discussed as a biomarker in prostate cancer (PC). However, some reports question the predictive property of AR-Vs. From a mechanistic perspective, the connection between AR
Externí odkaz:
https://doaj.org/article/2099e95770b44143932183ee7f6b5264
Autor:
Katrin Schlack, Konstantin Seitzer, Neele Wüstmann, Verena Humberg, Norbert Grundmann, Julie Steinestel, Dorothee Tiedje, Kambiz Rahbar, Laura-Maria Krabbe, Martin Bögemann, Andres J. Schrader, Christof Bernemann
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Biomarker in metastatic castration resistant prostate cancer (mCRPC) treatment are rare. We aimed to compare the clinical value of circulating tumor cells (CTCs) and androgen receptor splice variant 7 (AR-V7) as biomarker in mCRPC patients u
Externí odkaz:
https://doaj.org/article/68fc05281a2f455ba029b1959b708c40
Autor:
Robert Seifert, Sazan Rasul, Konstantin Seitzer, Maria Eveslage, Laya Rahbar Nikoukar, Katharina Kessel, Michael Schäfers, Josef Yu, Alexander R. Haug, Marcus Hacker, Martin Bögemann, Lisa Bodei, Michael J. Morris, Michael S. Hofman, Kambiz Rahbar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c660100f27527fb65e8a0af53e6e2c
https://www.ncbi.nlm.nih.gov/pubmed/37070991
https://www.ncbi.nlm.nih.gov/pubmed/37070991
Autor:
Manuel Weber, Katharina Kessel, Matthias Weckesser, Martin Bögemann, Katrin Schlack, Kambiz Rahbar, David Kersting, Robert Seifert, Konstantin Seitzer
Publikováno v:
Theranostics
Background: [¹⁷⁷Lu]-PSMA-617 (Lu-PSMA) therapy is a promising therapeutic option for end-stage prostate cancer patients. Early treatment response at the first restaging after two therapy cycles might correlate with high treatment efficacy and lo
Autor:
Matthias Weckesser, Kambiz Rahbar, Konstantin Seitzer, Ken Herrmann, Martin Boegemann, Michael Schäfers, Katharina Kessel, Robert Seifert, Jens Kleesiek
Publikováno v:
Theranostics
Rationale: PSMA-PET-CT enables measuring molecular expression of prostate-specific membrane antigen (PSMA) in vivo, which is the target molecule of 177Lu-PSMA-617 (Lu-PSMA) therapy. However, the correlation of PSMA expression and overall survival (OS
Autor:
Martin Boegemann, Katrin Schlack, Wolfgang Roll, Robert Seifert, Konstantin Seitzer, Katharina Kessel, Kambiz Rahbar
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3715, p 3715 (2021)
Cancers, Vol 13, Iss 3715, p 3715 (2021)
Simple Summary For patients with advanced prostate cancer, many different treatment options are available. One option is the radioligand therapy with 177Lutetium labelled prostate-specific membrane antigen (Lu-PSMA). This treatment showed good result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd0d57655c03c9ca64c5521d185d1c25
https://www.ncbi.nlm.nih.gov/pubmed/34359614
https://www.ncbi.nlm.nih.gov/pubmed/34359614
Autor:
Julie Steinestel, Christof Bernemann, Laura-Maria Krabbe, Katrin Schlack, Dorothee Tiedje, Martin Boegemann, Andres Jan Schrader, Norbert Grundmann, Konstantin Seitzer
e17547 Background: Playing an important role in prostate cancer, androgen receptor (AR) signaling is a common therapeutic target. Novel hormonal treatment (NHT) using enza or abi prolongs overall survival in men with metastatic castration-resistant p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74687dcb7c5ae9055412c161a7260dd
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/84054
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/84054